Cart
sales@molnova.com
MsbA inhibitor 1
CAS No. 52535-76-9
MsbA inhibitor 1 ( —— )
Catalog No. M14858 CAS No. 52535-76-9
MsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 1008 | Get Quote |
|
| 100MG | 1602 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMsbA inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor.
-
DescriptionMsbA inhibitor 1 is a novel small molecule lipopolysaccharide biogenesis inhibitor, inhibits MsbA, an ATP-dependent flippase that translocates LPS across the inner membrane; causes mislocalization of LPS to the cell interior, inhibits Δ5 strain with MIC of 0.2 ug/ml.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number52535-76-9
-
Formula Weight335.80
-
Molecular FormulaC16H14ClNO3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-(4-chlorobenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang G, et al. Proc Natl Acad Sci U S A. 2018 May 7. pii: 201804670.
molnova catalog
related products
-
6-FABA
6-FABA (6-Fluoroanthranilic Acid) is a small-molecule inhibitor of MTB tryptophan synthesis that converts Mtb into a tryptophan auxotroph and restores the efficacy of a failed host defense.
-
NSC624548
A small molecule that inhibits the activities of E. coli DNA polymerase I and calf thymus DNA polymerase alpha.
-
PA-824
A anti-tuberculosis agent that inhibits the synthesis of protein and cell wall lipid; exhibits bactericidal activity against both replicating and static M. tuberculosis (MIC: 0.015-0.25 ug/mL).
